{"id":"NCT00736957","sponsor":"Janssen Pharmaceutical K.K.","briefTitle":"A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain","officialTitle":"A Study of a Long-term Administration of JNS013 in Patients With Chronic Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2009-10","completion":"2009-11","firstPosted":"2008-08-18","resultsPosted":"2013-06-20","lastUpdate":"2014-07-02"},"enrollment":219,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pain"],"interventions":[{"type":"DRUG","name":"Tramadol Hydrochloride (HCL) plus Acetaminophen (JNS013)","otherNames":[]}],"arms":[{"label":"Tramadol HCL plus Acetaminophen","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of tramadol hydrochloride plus acetaminophen (JNS013) with long term administration in participants with chronic pain.","primaryOutcome":{"measure":"Change From Baseline in Visual Analogue Scale (VAS24) Score at Week 4","timeFrame":"Baseline and Week 4","effectByArm":[{"arm":"Tramadol Hydrochloride Plus Acetaminophen (JNS013)","deltaMin":65.8,"sd":11.629}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":25,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":190},"commonTop":["Nausea","Constipation","Vomiting","Dizziness","Nasopharyngitis"]}}